
Please try another search
ZYUS Life Sciences Corporation manufactures and distributes cannabinoid-based therapeutics and product candidates in Canada, the United States, Australia, and the European Union. The company offers Trichomylin, a softgel capsules with fixed dose combination of cannabinoids formulated that is phase 2 clinical trial for the treatment of chronic pain in adults caused due to musculoskeletal injuries, arthritis, and cancer. ZYUS Life Sciences Corporation was founded in 2018 and is headquartered in Saskatoon, Canada.
Name | Age | Since | Title |
---|---|---|---|
Garnette Weber | - | - | Independent Director |
John Knowles | - | - | Independent Director |
Brent H. Zettl | 63 | 2023 | President, CEO, Secretary & Director |
Richard Hoyt | - | - | Independent Chairman |
Charlotte Moore Hepburn | 48 | 2015 | Independent Director |
Wayne Richard Brownlee | 71 | 2023 | Independent Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review